These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 25311916

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A, Dorado P, Fricke-Galindo I, Jung-Cook H, Monroy-Jaramillo N, Martínez-Juárez IE, Familiar-López I, Peñas-Lledó E, LLerena A, López-López M.
    Pharmacogenomics J; 2016 Jun; 16(3):286-92. PubMed ID: 26122019
    [Abstract] [Full Text] [Related]

  • 3. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
    Liao K, Liu Y, Ai CZ, Yu X, Li W.
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):337-346. PubMed ID: 29628024
    [Abstract] [Full Text] [Related]

  • 4. [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].
    Huang Y, Yang JF, Qi XL, Wang YQ, Wang WZ, Chen B.
    Zhonghua Yi Xue Za Zhi; 2004 Oct 17; 84(20):1686-9. PubMed ID: 15569425
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement.
    van der Weide J, Steijns LS, van Weelden MJ, de Haan K.
    Pharmacogenetics; 2001 Jun 17; 11(4):287-91. PubMed ID: 11434505
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting.
    Lee SY, Lee ST, Kim JW.
    J Biochem Mol Biol; 2007 May 31; 40(3):448-52. PubMed ID: 17562299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin-Induced Cutaneous Adverse Drug Reactions.
    Fohner AE, Rettie AE, Thai KK, Ranatunga DK, Lawson BL, Liu VX, Schaefer CA.
    Clin Transl Sci; 2020 Sep 31; 13(5):1004-1009. PubMed ID: 32216088
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.
    Saldaña-Cruz AM, León-Moreno LC, Sánchez-Corona J, Santiago DA, Mendoza-Carrera F, Castro-Martínez XH, García-Zapién AG, Morán-Moguel MC, Flores-Martínez SE.
    Genet Test Mol Biomarkers; 2016 Nov 31; 20(11):702-709. PubMed ID: 27617498
    [Abstract] [Full Text] [Related]

  • 17. Investigating the Correlation between Genotypes and Hepatic Protein Expression of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 Using Postmortem Tissue from a Danish Population.
    Pedersen KW, Andersen JD, Hansen J, Børsting C, Banner J, Hasselstrøm JB, Jornil JR.
    Drug Metab Dispos; 2024 Aug 14; 52(9):975-980. PubMed ID: 38906700
    [Abstract] [Full Text] [Related]

  • 18. Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms.
    Hung CC, Lin CJ, Chen CC, Chang CJ, Liou HH.
    Ther Drug Monit; 2004 Oct 14; 26(5):534-40. PubMed ID: 15385837
    [Abstract] [Full Text] [Related]

  • 19. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR, Kulkarni NB, Gandhe PP, Thelma BK, Ravat SH, Gogtay NJ, Thatte UM.
    J Postgrad Med; 2014 Oct 14; 60(3):265-9. PubMed ID: 25121365
    [Abstract] [Full Text] [Related]

  • 20. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S, Wafai ZA, Wani MA, Jan TR, Andrabi KI.
    Int J Clin Pharmacol Ther; 2015 Jul 14; 53(7):504-16. PubMed ID: 25943175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.